NCT03688178
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03688178
Title DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab (DERIVe)
Acronym DERIVe
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gary Archer Ph.D.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field